Jeremy Grantham Bio Rad Laboratories, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$31.4 Billion
Q3 2024

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 82,799 shares of BIO stock, worth $27.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

82,799

Previous 96,133 13.87%

Holding current value

$27.1 Million

Previous $26.3 Million 5.52%

% of portfolio

0.09%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$263.97 - $344.64 $3.52 Million - $4.6 Million	-13,334 Reduced 13.87%	82,799 $27.7 Million
Q2 2024 Aug 13, 2024	BUY	$268.26 - $339.48 $746,031 - $944,093	2,781 Added 2.98%	96,133 $26.3 Million
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $1.74 Million - $2.02 Million	-5,738 Reduced 5.79%	93,352 $32.3 Million
Q4 2023 Feb 13, 2024	BUY	$269.37 - $365.04 $4.48 Million - $6.08 Million	16,647 Added 20.19%	99,090 $32 Million
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $1.87 Million - $2.26 Million	5,339 Added 6.92%	82,443 $29.6 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $4.21 Million - $5.69 Million	11,704 Added 17.9%	77,104 $29.2 Million
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $753,642 - $905,400	-1,800 Reduced 2.68%	65,400 $31.3 Million
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $3.8 Million - $4.92 Million	10,800 Added 19.15%	67,200 $28.3 Million
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $1.11 Million - $1.52 Million	2,700 Added 5.03%	56,400 $23.5 Million
Q2 2022 Aug 12, 2022	BUY	$463.67 - $597.16 $4.27 Million - $5.49 Million	9,200 Added 20.67%	53,700 $26.6 Million
Q1 2022 May 13, 2022	BUY	$524.57 - $735.42 $8.08 Million - $11.3 Million	15,400 Added 52.92%	44,500 $25.1 Million
Q4 2021 Feb 11, 2022	BUY	$708.84 - $794.68 $4.61 Million - $5.17 Million	6,500 Added 28.76%	29,100 $22 Million
Q3 2021 Nov 12, 2021	BUY	$657.71 - $825.77 $1.97 Million - $2.48 Million	3,000 Added 15.31%	22,600 $16.9 Million
Q2 2021 Aug 12, 2021	BUY	$576.64 - $649.04 $11.3 Million - $12.7 Million	19,600 New	19,600 $12.6 Million
Q2 2019 Aug 13, 2019	SELL	$286.93 - $312.59 $631,246 - $687,698	-2,200 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$224.3 - $317.41 $22,430 - $31,741	-100 Reduced 4.35%	2,200 $672,000
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $86,783 - $97,845	-300 Reduced 11.54%	2,300 $720,000
Q1 2018 May 15, 2018	BUY	$233.97 - $274.11 $23,397 - $27,411	100 Added 4.0%	2,600 $650,000
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $542,350 - $678,250	2,500	2,500 $597,000

Others Institutions Holding BIO

# of Institutions

456

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.07B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account